Back to User profile » Dr Wang Jing
Papers published by Dr Wang Jing:
Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Li J, Jing W, Zhai X, Jia W, Zhu H, Yu J
OncoTargets and Therapy 2021, 14:1623-1631
Published Date: 2 March 2021
Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases
Tian Y, Zhai X, Tian H, Jing W, Zhu H, Yu J
Cancer Management and Research 2019, 11:10083-10092
Published Date: 29 November 2019
Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study
An N, Wang H, Li J, Zhai X, Jing W, Jia W, Kong L, Zhu H, Yu J
OncoTargets and Therapy 2019, 12:8311-8318
Published Date: 8 October 2019
Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report
An N, Wang H, Zhu H, Yan W, Jing W, Kong L, Zhang Y, Yu J
OncoTargets and Therapy 2019, 12:7399-7404
Published Date: 10 September 2019
Clinical value of carcinoembryonic antigen for predicting the incidence of brain metastases and survival in small cell lung cancer patients treated with prophylactic cranial irradiation
Guo D, Jing W, Zhu H, Li MH, Zou B, Zhang Y, Fu L, Kong L, Yue J, Yu J
Cancer Management and Research 2018, 10:3199-3205
Published Date: 4 September 2018
The prognostic value of nodal skip metastasis in resectable thoracic esophageal squamous cell carcinoma
Song G, Jing W, Xue S, Guo H, Yu J
OncoTargets and Therapy 2017, 10:2729-2736
Published Date: 25 May 2017